Edgewise Therapeutics (EWTX) Interest Coverage Ratio (2020 - 2025)
Edgewise Therapeutics (EWTX) reported Interest Coverage Ratio of 0.22 for Q4 2025, down 28.53% on a YoY basis from 0.31 in Q4 2024, and down 28.53% sequentially from 0.17 in Q4 2024.
Edgewise Therapeutics (EWTX) Interest Coverage Ratio (2020 - 2025) Analysis & Trends
Edgewise Therapeutics (EWTX) has 6 years of Interest Coverage Ratio data on file, last reported at 0.22 in Q4 2025.
- For the quarter ending Q4 2025, Interest Coverage Ratio fell 28.53% year-over-year to 0.22; the trailing twelve-month figure through Dec 2025 stood at 0.75 (down 26.01% YoY), and the FY2025 full-year result was 0.75, down 26.01% from the prior year.
- Interest Coverage Ratio fell to 0.22 in Q4 2025, from 0.17 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 0.17 in Q4 2024 to a low of 638.91 in Q4 2023.
- A 5-year average of 63.75 and a median of 5.45 in 2024 frame the typical range for Interest Coverage Ratio.
- Across the five-year window, Interest Coverage Ratio sank 8083.31% in 2022 and soared 99.97% in 2024, its largest moves.
- Tracing EWTX's Interest Coverage Ratio over 5 years: stood at 0.62 in 2021, then slumped by 8083.31% to 51.11 in 2022, then sank by 1150.09% to 638.91 in 2023, then soared by 99.97% to 0.17 in 2024, then dropped by 28.53% to 0.22 in 2025.
- Business Quant data shows EWTX's Interest Coverage Ratio at 0.22 in Q4 2025, 0.17 in Q4 2024, and 35.75 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Edgewise Therapeutics | 4.21 Bn | 4.21 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.22 |
| Dec 31, 2024 | -0.17 |
| Jun 30, 2024 | -35.75 |
| Mar 31, 2024 | -5.45 |
| Dec 31, 2023 | -638.91 |
| Sep 30, 2023 | -22.78 |
| Jun 30, 2023 | -3.61 |
| Mar 31, 2023 | -3.62 |
| Dec 31, 2022 | -51.11 |
| Sep 30, 2022 | -25.90 |
| Jun 30, 2022 | -36.09 |
| Mar 31, 2022 | -4.49 |
| Dec 31, 2021 | -0.62 |
| Dec 31, 2020 | -0.72 |